BioXcel Therapeutics, Inc. short interest in 2026
In 2026, BioXcel Therapeutics, Inc.'s disclosed short interest ran from 6.25% of shares outstanding on 15 Jan 2026 to 14.94% on 15 Jul 2026, a change of +8.69 percentage points. The year's high was 15.94% on 15 Jun 2026 and its low 6.25% on 15 Jan 2026, averaging 12.04% across 13 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.46 days on 27 Feb 2026. Full history: BioXcel Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 6.25% (15 Jan 2026)
- End of year
- 14.94% (15 Jul 2026)
- Change
- +8.69 pp
- High
- 15.94% (15 Jun 2026)
- Low
- 6.25% (15 Jan 2026)
- Average
- 12.04%
- Highest days to cover
- 7.46 (27 Feb 2026)
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 6.25% | 1.91 | |
| 30 Jan 2026 | 6.98% | 2.71 | |
| 13 Feb 2026 | 8.86% | 5.61 | |
| 27 Feb 2026 | 8.58% | 7.46 | |
| 13 Mar 2026 | 12.83% | 1.00 | |
| 31 Mar 2026 | 12.23% | 4.58 | |
| 15 Apr 2026 | 14.58% | 3.08 | |
| 30 Apr 2026 | 15.67% | 4.78 | |
| 15 May 2026 | 13.13% | 5.66 | |
| 29 May 2026 | 13.02% | 4.47 | |
| 15 Jun 2026 | 15.94% | 6.85 | |
| 30 Jun 2026 | 13.53% | 5.92 | |
| 15 Jul 2026 | 14.94% | 1.64 |
See also: BioXcel Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.